Comments
Loading...
Larimar Therapeutics (NASDAQ:LRMR) Stock, Earnings Estimates, EPS, And Revenue
Larimar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$-0.320
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Larimar Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Larimar Therapeutics (LRMR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-30 | $-0.24 | $-0.37 | 35.1 % |
| Q2 | 2024-08-07 | $-0.34 | $-0.30 | -13.3 % |
| Q1 | 2024-05-09 | $-0.27 | $-0.24 | -12.5 % |
| Q4 | 2024-03-14 | $-0.30 | $-0.25 | -20.0 % |
Larimar Therapeutics (LRMR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?
Larimar Therapeutics (LRMR) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
What were the latest earnings per share (EPS) for Larimar Therapeutics (NASDAQ:LRMR)?
The Actual EPS was $-0.24, which beat the estimate of $-0.37.
What were Larimar Therapeutics’s (NASDAQ:LRMR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.